Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AJ Integrase inhibitors
J05AJ03 Dolutegravir
D10113 Dolutegravir sodium (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Antivirals
Anti-HIV Agents, Integrase Inhibitors (INSTI)
Dolutegravir
D10113 Dolutegravir sodium (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D10113 Dolutegravir sodium (JAN/USAN)
Drug groups [BR:br08330]
Antiviral
DG03107 Anti-HIV agent
DG03135 HIV integrase inhibitor
DG00667 Dolutegravir
D10113 Dolutegravir sodium
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00667 Dolutegravir
D10113 Dolutegravir sodium
DG02924 UGT substrate
DG03183 UGT1A1 substrate
DG00667 Dolutegravir
D10113 Dolutegravir sodium
Transporter inhibitor
DG02863 SLC22A2 inhibitor
DG00667 Dolutegravir
D10113 Dolutegravir sodium
DG02864 SLC47A1 inhibitor
DG00667 Dolutegravir
D10113 Dolutegravir sodium
Drug classes [BR:br08332]
Antiviral
DG03107 Anti-HIV agent
D10113 Dolutegravir sodium
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV integrase inhibitor
D10113 Dolutegravir sodium (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10113
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10113
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10113
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10113
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10113
Drug transporters
D10113
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D10113
Drug groups [BR:br08330]
Antiviral
DG03107 Anti-HIV agent
DG03135 HIV integrase inhibitor
DG00667 Dolutegravir
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00667 Dolutegravir
DG02924 UGT substrate
DG03183 UGT1A1 substrate
DG00667 Dolutegravir
Transporter inhibitor
DG02863 SLC22A2 inhibitor
DG00667 Dolutegravir
DG02864 SLC47A1 inhibitor
DG00667 Dolutegravir
Antimicrobials abbreviations [BR:br08327]
Antivirals
Genome replication inhibitor
HIV integrase inhibitor
DG00667 Dolutegravir